Back to results
US 8,278,415 B2Granted
Dimeric high affinity EGFR constructs and uses thereof
AssigneeCentocor, Inc.
InventorsWang Bryan, Frank Shi, Juliane Mills
Life of this patent
Estimating the term…
Abstract
Polypeptides comprising EGFR extracellular domains I-III capable of forming dimeric EGF-binding proteins are provided. The dimeric construct of the invention is useful in applications where high affinity EGF binding is desired and can be used to select agents capable of binding to native EGFR in the presence of EGF.
Claims2
A composition comprising a fusion protein according to the formula:
- V1o-Pepa-Flexn-V2m-Hinge-CH2-CH3 (I)
- and wherein Pep represents domains I to III of human EGFR capable of binding EGF with an affinity of less than 1 nM when measured by BIAcore, V1 is the sequence QIQ, Flex is a flexible linker peptide, V2 represents a sequence derived from an immunoglobulin J gene domain and is TLVTVSS (SEQ ID No:61), the hinge, CH2 and CH3 are domains from a human IgG1 and each of a, m, n and o is equal to 1, wherein the fusion protein comprises SEQ ID NO:2.
A dimeric polypeptide comprising two polypeptides of sequence SEQ ID NO:2.
Dependencies are inferred from the claim text.